<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M787</article-id>
      <article-id pub-id-type="publisher-id">molbank-2012-M787</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Diethyl 4-(6-Chloroimidazo[2,1-<italic>b</italic>]thiazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate and Ethyl 4-(6-Chloroimidazo[2,1-<italic>b</italic>]thiazol-5-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Morigi</surname>
            <given-names>Rita</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Locatelli</surname>
            <given-names>Alessandra</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rambaldi</surname>
            <given-names>Mirella</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Consorti</surname>
            <given-names>Alessandro</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leoni</surname>
            <given-names>Alberto</given-names>
          </name>
          <xref rid="c1-molbank-2012-M787" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2012-M787">Department of Pharmacy and Biotechnologies FaBiT, University of Bologna, via Belmeloro 6, 40126 Bologna, Italy</aff>
      <author-notes>
        <corresp id="c1-molbank-2012-M787"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>alberto.leoni@unibo.it</email>.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>11</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>12</month>
        <year>2012</year>
      </pub-date>
      <volume>2012</volume>
      <issue>4</issue>
      <elocation-id>M787</elocation-id>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>10</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>11</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2012 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>Diethyl 4-(6-chloroimidazo[2,1-<italic>b</italic>]thiazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate and ethyl 4-(6-chloroimidazo[2,1-<italic>b</italic>]thiazol-5-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate were obtained simultaneously by the Biginelli reaction using a green protocol and curtailing reaction time.</p>
      </abstract>
      <kwd-group>
        <kwd>3,4-dihydropyrimidin-2(1<italic>H</italic>)-ones</kwd>
        <kwd>1,4-dihydropyridines</kwd>
        <kwd>imidazo[2,1-<italic>b</italic>]thiazole</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>Molecular scaffolds such as 3,4-dihydropyrimidin-2(1<italic>H</italic>)-ones (DHPMs), synthesized the first time by Biginelli reaction [<xref ref-type="bibr" rid="B1-molbank-2012-M787">1</xref>], fascinated both biologists and medicinal chemists for their polyhedral pharmacological worth and the synthetic challenge to improve reaction conditions and yields. DHPMs motifs appropriately decorated, as far as 1,4-dihydropyridines (1,4-DHPs), play a role in a large range of activities: antitumor [<xref ref-type="bibr" rid="B2-molbank-2012-M787">2</xref>], antihypertensive [<xref ref-type="bibr" rid="B3-molbank-2012-M787">3</xref>], antitubercular [<xref ref-type="bibr" rid="B4-molbank-2012-M787">4</xref>]. Interestingly, the imidazo[2,1-<italic>b</italic>]thiazole is a well-known system able to endow 1,4-DHPs specific activities such as the cardiovascular [<xref ref-type="bibr" rid="B5-molbank-2012-M787">5</xref>] one. Moreover, 3,4-DHPMs bearing an imidazo[2,1-<italic>b</italic>]thiazole system are still unknown in literature and they could show new and interesting activities. For these reasons, we focused our study on the synthesis of a library of 3,4-DHPMs and 1,4-DHPs bearing an imidazo[2,1-<italic>b</italic>]thiazole system, using a Biginelli reaction protocol [<xref ref-type="bibr" rid="B6-molbank-2012-M787">6</xref>]. This procedure is green, fast, cheap to apply and assures the simultaneous production of both 1,4-DHPs and 3,4-DHPMs by means of a <italic>one-pot</italic> system. The present paper reports the synthesis of compounds <bold>2</bold> and <bold>3</bold> (see <xref ref-type="scheme" rid="molbank-2012-M787-sch001">Scheme 1</xref>).</p>
      <p>The aldehyde <bold>1</bold> was synthesized by Vilsmeier formylation of the imidazo[2,1-<italic>b</italic>]thiazole scaffold as previously described [<xref ref-type="bibr" rid="B7-molbank-2012-M787">7</xref>], then compound <bold>1</bold> was submitted to the Biginelli cyclocondensation, applying a method reported by Ranu <italic>et al.</italic> [<xref ref-type="bibr" rid="B6-molbank-2012-M787">6</xref>] (<xref ref-type="scheme" rid="molbank-2012-M787-sch001">Scheme 1</xref>) and modified to be suitable for the imidazo[2,1-<italic>b</italic>]thiazole moiety.</p>
	  <fig id="molbank-2012-M787-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2012-M787-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Synthesis of the title compounds <bold>2</bold> and <bold>3</bold>.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2012-M787-sch001.tif"/>
      </fig>
    <sec sec-type="methods">
      <title>Experimental</title>
      <sec>
        <title>General</title>
        <p>The melting points are uncorrected. TLC analysis were performed on Bakerflex plates (silica gel IB2-F). Kieselgel 60 (VWR, Milan, Italy) was used for flash chromatography. The IR spectra were recorded in nujol on a Nicolet Avatar 320 E.S.P.; &#x3BD;<sub>max</sub> are expressed in cm<sup>&#x2212;1</sup>. The <sup>1</sup>H-NMR and <sup>13</sup>C-NMR spectra were recorded in DMSO-<italic>d<sub>6</sub></italic> on a Varian MR 400 MHz (ATB PFG probe); the chemical shifts (referenced to solvent signal) are expressed in ppm (&#x3B4;) and <italic>J</italic> in Hz (abbreviations: th = thiazole, py = pyridine, pym = pyrimidinone). Urea and ethyl acetoacetate were purchased from Sigma Aldrich and were used as delivered without further purification, whereas aldehyde <bold>1</bold> was prepared according to the literature [<xref ref-type="bibr" rid="B7-molbank-2012-M787">7</xref>].</p>
      </sec>
      <sec>
        <title>Diethyl 4-(6-Chloroimidazo[2,1-b]thiazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate <italic>(<bold>2</bold>)</italic>, Ethyl 4-(6-Chloroimidazo[2,1-b]thiazol-5-yl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate <italic>(<bold>3</bold>)</italic></title>
        <p>Aldehyde <bold>1</bold> (2 g, 0.01 mol) was mixed homogeneously with ethyl acetoacetate (1.4 mL, 0.01 mol) and urea (0.96 g, 0.01 mol). The mixture was stirred at 125&#x2013;130 &#xB0;C for two hours according to a TLC test, the eluent was a mixture of dichloromethane/ethanol 9:1. Afterwards, the mixture was allowed to cool at room temperature. The black fused solid obtained was grinded to get a powder, added to hot water (30 mL) and filtered off by suction. The washed powder was then purified by flash chromatography eluting with a gradient of acetone/petroleum ether from 0:1 to 6:4, v/v. After separation, a yellow solid and an orange powder were obtained, corresponding to analytically pure samples of compounds <bold>2</bold> (yield 15%) and <bold>3</bold> (yield 45%) respectively.</p>
      </sec>
      <sec>
        <title>Data for Compound <italic><bold>2</bold></italic></title>
        <p>M.p.: 165 &#xB0;C.</p>
        <p>IR (nujol, cm<sup>&#x2212;1</sup>): 1653, 1458, 1377, 1272, 1160.</p>
        <p><sup>1</sup>H-NMR (400 MHz, DMSO-<italic>d<sub>6</sub></italic>) &#x3B4; (ppm): 0.97 (6H, t, COOCH<sub>2</sub>C<italic>H<sub>3</sub></italic>, <italic>J</italic> = 7.2), 2.25 (6H, s, CH<sub>3</sub>), 3.91 (4H, m, COOC<italic>H<sub>2</sub></italic>CH<sub>3</sub>), 5.20 (1H, s, py), 7.32 (1H, d, th, <italic>J</italic> = 4.8), 7.77 (1H, d, th, <italic>J</italic> = 4.8), 9.04 (1H, s, NH).</p>
        <p><sup>13</sup>C-NMR (400 MHz, DMSO-<italic>d<sub>6</sub></italic>) &#x3B4; (ppm): 14.99, 18.87, 31.47, 60.03, 98.22, 113.09, 120.88, 129.20, 131.08, 144.87, 147.02, 167.53.</p>
        <p>Anal. Calculated for C<sub>18</sub>H<sub>20</sub>ClN<sub>3</sub>O<sub>4</sub>S (MW 409.89): 52.74 (C), 4.92 (H), 10.25 (N). Found: 52.75 (C), 4.92 (H), 10.24 (N).</p>
      </sec>
      <sec>
        <title>Data for Compound <italic><bold>3</bold></italic></title>
        <p>M.p.: 195 &#xB0;C.</p>
        <p>IR (nujol, cm<sup>&#x2212;1</sup>): 1694, 1555, 1375, 1283, 1021.</p>
        <p><sup>1</sup>H-NMR (400 MHz, DMSO-<italic>d<sub>6</sub></italic>) &#x3B4; (ppm): 0.95 (3H, t, COOCH<sub>2</sub>C<italic>H<sub>3</sub></italic>, <italic>J</italic> = 7.0), 2.26 (3H, s, CH<sub>3</sub>), 3.90 (2H, m, COOC<italic>H<sub>2</sub></italic>CH<sub>3</sub>), 5.70 (1H, d, pym, <italic>J</italic> = 2), 7.41 (1H, d, th, <italic>J</italic> = 4.2), 7.71 (1H, s, NH), 7.77 (1H, d, th, <italic>J</italic> = 4.2), 9.43 (1H, s, NH).</p>
        <p><sup>13</sup>C-NMR (400 MHz, DMSO-<italic>d<sub>6</sub></italic>) &#x3B4; (ppm): 14.87, 18.61, 46.81, 60.14, 95.07, 114.52, 120.14, 125.63, 130.60, 146.18, 150.13, 151.94, 165.84.</p>
        <p>Anal. Calculated for C<sub>13</sub>H<sub>13</sub>ClN<sub>4</sub>O<sub>3</sub>S (MW 340.79): 45.82 (C), 3.85 (H), 16.44 (N). Found: 45.84 (C), 3.84 (H), 16.45 (N).</p>
      </sec>
    </sec>
  </body>
  <back>
   <app-group>
    <app id="app1-molbank-2012-M787">
        <title>Supplementary materials</title>
		<supplementary-material id="molbank-2012-M787-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2012-M787-s001.pdf">
	<label>Supplementary File 1</label>
	</supplementary-material>
        <supplementary-material id="molbank-2012-M787-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2012-M787-s002-mod.mol">
	<label>Supplementary File 2</label>
	</supplementary-material>
        <supplementary-material id="molbank-2012-M787-s003" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2012-M787-s002.mol">
	<label>Supplementary File 3</label>
	</supplementary-material>
    </app>
	</app-group>
    <ack>
      <title>Acknowledgements</title>
      <p>This work has been supported by a grant from the University of Bologna (RFO).</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2012-M787">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Biginelli</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Intorno ad uramidi aldeidiche dell&#x2019;etere acetilacetico</article-title>
          <source>Gazz. Chim. Ital.</source>
          <year>1891</year>
          <fpage>497</fpage>
          <lpage>500</lpage>
        </citation>
      </ref>
      <ref id="B2-molbank-2012-M787">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suresh</surname>
             </name>
            <name>
              <surname>Sandhu</surname>
              <given-names>J.S.</given-names>
            </name>
          </person-group>
          <article-title>Past, present and future of the Biginelli reaction: A critical perspective</article-title>
          <source>Arkivoc</source>
          <year>2012</year>
          <volume>i</volume>
          <fpage>66</fpage>
          <lpage>133</lpage>
        </citation>
      </ref>
      <ref id="B3-molbank-2012-M787">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kastron</surname>
              <given-names>V.V.</given-names>
            </name>
            <name>
              <surname>Vitolin</surname>
              <given-names>R.O.</given-names>
            </name>
            <name>
              <surname>Khanina</surname>
              <given-names>E.L.</given-names>
            </name>
            <name>
              <surname>ya Duburs</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Kimenis</surname>
              <given-names>A.A.</given-names>
            </name>
          </person-group>
          <article-title>Fluorine-containing derivatives of 1,2,3,4-tetrahydropyrimidine: Synthesis and pharmacological activity</article-title>
          <source>Khim. Farm. Zh.</source>
          <year>1987</year>
          <volume>21</volume>
          <fpage>948</fpage>
          <lpage>952</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00759433</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2012-M787">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trivedi</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Bhuva</surname>
              <given-names>V.R.</given-names>
            </name>
            <name>
              <surname>Dholariya</surname>
              <given-names>B.H.</given-names>
            </name>
            <name>
              <surname>Dodiya</surname>
              <given-names>D.K.</given-names>
            </name>
            <name>
              <surname>Kataria</surname>
              <given-names>V.B.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>V.H.</given-names>
            </name>
          </person-group>
          <article-title>Novel dihydropyrimidines as a potential new class of antitubercular agents</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2010</year>
          <volume>20</volume>
          <fpage>6100</fpage>
          <lpage>6102</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2010.08.046</pub-id>
          <pub-id pub-id-type="pmid">20813528</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2012-M787">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Budriesi</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Ioan</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Locatelli</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Leoni</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Cosconati</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>di Toro</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Chiarini</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Spampinato</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Marinelli</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Novellino</surname>
              <given-names>E.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Imidazo[2,1-<italic>b</italic>]thiazole system: A scaffold endowning dihydropyridines with selective cardiopressant activity</article-title>
          <source>J. Med. Chem.</source>
          <year>2008</year>
          <volume>51</volume>
          <fpage>1592</fpage>
          <lpage>1600</lpage>
          <pub-id pub-id-type="doi">10.1021/jm070681+</pub-id>
          <pub-id pub-id-type="pmid">18303827</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2012-M787">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ranu</surname>
              <given-names>B.C.</given-names>
            </name>
            <name>
              <surname>Hajra</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Dey</surname>
              <given-names>S.S.</given-names>
            </name>
          </person-group>
          <article-title>A practical and green approach towards synthesis of Dihydropyrimidinones without any solvent or catalyst</article-title>
          <source>Org. Process Res. Dev.</source>
          <year>2002</year>
          <volume>6</volume>
          <fpage>817</fpage>
          <lpage>818</lpage>
          <pub-id pub-id-type="doi">10.1021/op0255478</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2012-M787">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andreani</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Rambaldi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Locatelli</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Andreani</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>5-Formylimidazo[2,1-<italic>b</italic>]thiazoles and derivatives with herbidal acivity</article-title>
          <source>Collect. Czech. Chem. Commun.</source>
          <year>1991</year>
          <volume>56</volume>
          <fpage>2436</fpage>
          <lpage>2437</lpage>
          <pub-id pub-id-type="doi">10.1135/cccc19912436</pub-id>
        </citation>
      </ref>
    </ref-list>
   </back>
</article>
